跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,619 条关于
“Ysios Capital”
全部
3,619
临床试验
615
药物
15
机构
107
资讯
2,882
5个月前
Ysios Capital Launches €100M InceptionBio Fund to Catalyze Spanish Biotech Spinouts
7个月前
Memo Therapeutics Partners with CSL in $328 Million Deal for Recombinant Polyclonal IgG Technology
去年
NorthSea Therapeutics Strengthens Executive Team with Strategic CFO and CMO Appointments
9个月前
Memo Therapeutics' Potravitug Receives EU Orphan Designation for BK Polyomavirus Infection in Kidney Transplant Patients
3年前
VarmX Secures €30M Series B2 Funding to Advance Anticoagulation Reversal Drug VMX-C001 Toward Pivotal Trial
去年
Memo Therapeutics to Present Phase II Results for First-in-Class BK Polyomavirus Treatment at World Transplant Congress
去年
SpliceBio Raises $135 Million Series B to Advance Gene Therapy for Stargardt Disease Using Novel Protein Splicing Platform
8个月前
Memo Therapeutics Publishes First Study Mapping BK Polyomavirus Impact on Kidney Transplant Recipients' Quality of Life
8个月前
VarmX and Rentschler Biopharma Expand Partnership for Phase III Development of Novel Coagulation Therapy VMX-C001
6个月前
NorthSea Therapeutics Secures Orphan Drug Designations for Orziloben in Rare Liver Disease
第 1 页,共 289 页
上一页
下一页